Dosage chart, U-100 syringe units and supplies for a 10 mg vial of CJC-1295 mixed with 3 mL. For the full research summary, see the CJC-1295 page.
Amounts as reported for this peptide, with the syringe measure for this vial. Reported use is not evidence that a schedule works or is safe, and none of this is medical advice.
| Period | Amount each time | U-100 units | Volume |
|---|---|---|---|
| Weeks 1-2 | 100 mcg | 3 | 0.03 mL |
| Weeks 3-4 | 150 mcg | 4.5 | 0.05 mL |
| Weeks 5-6 | 200 mcg | 6 | 0.06 mL |
| Week 7 on | 250-300 mcg | 7.5-9 | 0.08-0.09 mL |
Minimum supplies for each length of the schedule above, with 10 mg vials and 3 mL of water per vial. One new syringe per injection (two if over 1 mL), two alcohol swabs per injection, 10 mL water bottles.
| Item | 8 weeks | 12 weeks | 16 weeks |
|---|---|---|---|
| Injections | 56 | 84 | 112 |
| Total peptide | 10.5 mg | 18.9 mg | 27.3 mg |
| CJC-1295 vials (10 mg) | 2 | 2 | 3 |
| Bacteriostatic water | 6 mL | 6 mL | 9 mL |
| Water bottles (10 mL) | 1 | 1 | 1 |
| U-100 insulin syringes | 56 | 84 | 112 |
| Alcohol swabs (boxes of 100) | 112 (2) | 168 (2) | 224 (3) |
For laboratory research use only.
Codex Research LabShips from Panama City · US domestic shipping
Try other volumes of water: the concentration and the units per amount change with it.
Arithmetic only. It assumes the vial holds exactly what the label says.
| Liquid added | Concentration | Per unit |
|---|---|---|
| 1 mL | 10,000 mcg/mL | 100 mcg |
| 2 mL | 5,000 mcg/mL | 50 mcg |
| 3 mL | 3,333 mcg/mL | 33.3 mcg |
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone designed to bind to albumin in the blood so it lasts for days. The short-acting "no DAC" version sold under the same name has no published human studies, and neither version is FDA-approved.
A 10 mg vial holds 10,000 mcg of CJC-1295. Adding 3 mL gives 3.33 mg/mL, so one U-100 unit (0.01 mL) holds 33.3 mcg. To get the units for an amount, divide it by 33.3 mcg. The units are a volume mark on the syringe, not a measure of potency.
Vial coverage by mass: 100 full amounts of 100 mcg, 66 full amounts of 150 mcg, 50 full amounts of 200 mcg, 40 full amounts of 250 mcg, 33 full amounts of 300 mcg per vial, before any handling loss.
If a different volume of water is used, every unit figure changes: recalculate with the calculator above.
All the published human data are for CJC-1295 with DAC, in healthy adults:
In short: the DAC version clearly raises growth hormone and IGF-1 for days to weeks in healthy adults, but these were small, short studies that measured hormone levels, not health outcomes. There are no published human data on the version without DAC, and the one patient trial was stopped without published results.
Every study dose, including animal and cell studies, is in the CJC-1295 dose table.
Human safety data come from small groups of healthy adults followed for up to about 7 weeks. No serious adverse reactions were reported, and the authors described doses of 30 or 60 µg/kg as relatively well tolerated (Teichman 2006). Long-term effects are unknown.
There is no single correct volume: it only changes the concentration. For a 10 mg vial, 1 mL gives 10,000 mcg/mL, 2 mL gives 5,000 mcg/mL, 3 mL gives 3,333 mcg/mL. More water makes small amounts easier to measure; less water keeps volumes small. Whatever volume is used, write it on the label.
On a U-100 syringe, 100 units = 1 mL, so one unit is 0.01 mL. How much peptide that holds depends on the concentration of the vial, which depends on how much water was added.
No. Animal doses are reported per kilogram for a different species, and scaling them to people is not reliable. That is why Upzo shows each study dose next to its study, unconverted.
Research and education only. Not medical advice. Many peptides on this site are not approved by the FDA for human use. Doses shown are the ones used in published studies and are not a recommendation. Talk to a licensed clinician before using any of them. Read the full disclaimer.
